Stem Cell Therapy May End Insulin for Type 1 Diabetics
A new stem cell therapy by Vertex helped 83% of type 1 diabetics eliminate insulin use—marking a potential paradigm shift in diabetes treatment.
Why the Iran Conflict Is Supercharging Defense AI Stocks
The Iran conflict is accelerating global defense tech investments—AI-driven firms like Palantir and Anduril are leading the charge.
Democratic Support for Clean Energy Takes a Hit
Support for clean energy programs is slipping—even among Democrats. Here’s what the latest polling data reveals, and why it could stall climate progress.
Why Stablecoins Are Quietly Reshaping U.S. Treasury Markets
Stablecoins now hold over $166 billion in U.S. Treasuries—more than Germany. This shift is redefining crypto’s role in global finance, creating new risks and opportunities for investors and policymakers.
Why ‘Made in Mexico’ Is the New ‘Made in China’: Inside the Nearshoring Boom
U.S. companies are rapidly shifting production to Mexico amid rising China tensions and supply chain risks. Here’s how nearshoring is reshaping global manufacturing.